BRIEF published on 05/19/2025 at 09:05, 11 months 21 days ago Cantourage Group SE réalise une croissance record de ses ventes Marge EBITDA Notation D'investissement Stratégies De Croissance Ventes De Disques Groupe Cantourage
BRIEF published on 05/19/2025 at 09:05, 11 months 21 days ago Cantourage Group SE Achieves Record Sales Growth EBITDA Margin Record Sales Investment Rating Growth Strategies Cantourage Group
PRESS RELEASE published on 05/19/2025 at 09:00, 11 months 21 days ago Original-Research: Cantourage Group SE (von NuWays AG): BUY Cantourage Group SE showing accelerated growth with €100m sales in sight. Analyst recommends BUY as sales surge 250% YoY BUY Rating Analyst Recommendation Cantourage Group SE Accelerated Growth €100m Sales
BRIEF published on 05/15/2025 at 07:12, 11 months 25 days ago Cantourage établit un nouveau record de revenus en avril 2025 Marché Européen Revenus Records Cannabis Médical Demande De Produits Trajectoire De Croissance
BRIEF published on 05/15/2025 at 07:12, 11 months 25 days ago Cantourage Sets New Revenue Record in April 2025 European Market Record Revenue Medical Cannabis Growth Trajectory Product Demand
PRESS RELEASE published on 05/15/2025 at 07:07, 11 months 25 days ago Cantourage achieves another record revenue: EUR 11.1 million in April 2025 Cantourage Group SE achieves record revenue of EUR 11.1 million in April 2025, driven by strong demand for medical cannabis products in European and international markets Record Revenue Medical Cannabis Cantourage Group SE Dynamic Growth European Markets
BRIEF published on 04/14/2025 at 09:05, 1 year ago Growth and Positive Outlook for Cantourage Group SE EBITDA Margin Stock Valuation Quarterly Sales Cantourage Growth Cannabis Regulation
BRIEF published on 04/14/2025 at 09:05, 1 year ago Croissance et perspectives positives pour Cantourage Group SE Marge D'EBITDA Évaluation Des Stocks Ventes Trimestrielles Croissance De Cantourage Réglementation Du Cannabis
PRESS RELEASE published on 04/14/2025 at 09:00, 1 year ago Original-Research: Cantourage Group SE (von NuWays AG): BUY Cantourage Group SE shows exceptional growth with Q1 sales surging to €25.6m, exceeding expectations. Analysts raise PT to €13 based on solid performance and potential market demand Growth Cantourage Group SE Market Demand Q1 Sales Analyst Rating
BRIEF published on 04/10/2025 at 09:08, 1 year ago Record Revenue for Cantourage in Q1 2025 European Market Sales Growth Medical Cannabis Cantourage Group SE Quarterly Revenue
Published on 05/09/2026 at 01:30, 10 hours 31 minutes ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 12 hours 1 minute ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/08/2026 at 20:38, 15 hours 23 minutes ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 16 hours 48 minutes ago EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 16 hours 59 minutes ago Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/07/2026 at 19:15, 1 day 16 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 1 day 16 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 1 day 16 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 1 day 16 hours ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 1 day 17 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
